Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Erez Ben Shem"'
Publikováno v:
Journal of Palliative Care. 38:184-191
Objective To evaluate the symptoms of women with epithelial ovarian cancer (EOC) during their last admission before death and analyze invasive palliative management administered in relation to symptom control and survival. Materials & Methods A retro
Autor:
Tally Levy, Erez Ben Shem, Yakov Oksman, Elinor Goshen, O Peled, Mordechai Lorberboym, Osnat Elyashiv, Ori Tal, Ehud Grinstein
Publikováno v:
Journal of Minimally Invasive Gynecology. 28:1531-1535
Study Objective To determine whether the concomitant use of indocyanine green (ICG) with technetium-99m–filtered sulfur colloid (Tc99m-FSC) improves bilateral sentinel lymph node (SLN) detection rate in endometrial cancer and whether anatomic conco
Publikováno v:
Rambam Maimonides Medical Journal, Vol 6, Iss 1, p e0005 (2015)
Objective: To assess the association between normal CA125 levels at diagnosis of epithelial ovarian carcinoma (EOC) with prognostic factors and with outcome. Methods: The study group consisted of histologically confirmed EOC patients with normal p
Externí odkaz:
https://doaj.org/article/ae8d6d3d44eb4f6dae0ef61c95c796b6
Publikováno v:
E-Poster viewings.
Objectives Response to platinum-based chemotherapy is considered to be one of the most important prognostic factors in recurrent ovarian cancer. Women with primary platinum resistance (PPR) have poor prognosis. Less is known regarding outcome in pati
Publikováno v:
E-Poster viewings.
Objectives To compare the treatment outcome and survival of patients with recurrence in retroperitoneal lymph nodes versus women with intraperitoneal recurrence. Methods This retrospective cohort study included patients treated for ovarian, tubal and
Autor:
Joseph Menczer, O Peled, Letizia Schreiber, Erez Ben Shem, Hananya Vaknine, Tally Levy, Masha Ben Zvi
Publikováno v:
Chemotherapy. 61:236-239
Subacute cutaneous lupus erythematosus (SCLE) is a rare eruption related to several pharmacological and chemotherapy agents. We present a 63-year-old female with recurrent epithelial ovarian cancer who developed SCLE after administration of gemcitabi
Publikováno v:
The Israel Medical Association journal : IMAJ. 20(4)
Uterine carcinosarcoma (UCS) is a rare tumor with a poor prognosis. An elevated thrombocyte count and thrombocytosis were found to be associated with poor prognosis in several gynecological tumors. Data regarding an elevated thrombocyte count and thr
Publikováno v:
Gynecologic Oncology. 129:165-168
Objective A rise of the CA125 marker above the normal range during follow-up of ovarian, primary peritoneal and tubal carcinoma patients with a complete clinical response after initial treatment signifies recurrence. We assessed whether the pattern o
Publikováno v:
Journal of Lower Genital Tract Disease. 2:61-65
Autor:
Joseph, Menczer, Letizia, Schreiber, Esther, Berger, Erez, Ben-Shem, Abraham, Golan, Tally, Levy
Publikováno v:
The Israel Medical Association journal : IMAJ. 16(11)
Background: Elevated serum levels of the epithelial marker CA125 are occasionally observed in leiomyosarcoma (LMS) patients.To assess the immunohistochemical expression of this marker in the tissue of LMS.The consecutive unselected records of all pat